neutralizing antibody in puromycin aminonucleoside nephropathy. In the present study, two series of experiments were done with PAN nephropathy rats given fibroblast growth factor 2 (FGF2) or FGF2 neutralizing antibodies. In the first series of experiments, a dose of 10 jg of FGF2 (FGF2 group), 40 jrg of an FGF2 neutralizing antibody (Anti-FGF2 group) or an equal volume of physiological saline (Control group) was administered for four days after PAN injection. Urinary protein increased more in the FGF2 group than in the other two groups. PCNA (+) glomerular cells were found in decreasing order in groups FGF2, Control and Anti-FGF2. Most of the PCNA (+) cells were podocytes and epithelial cells of Bowman's capsule. Staining for desniin, a marker of podocyte injury, was significantly reduced in the Anti-FGF2 group. Glomerular adhesive lesions were found in decreasing order in groups FGF2, Control and Anti-FGF2. The second series of experiments was designed to study the effects of FGF2 neutralizing antibody (40 jg for 5 days after PAN injection, in MoAb group) on severely damaged podocytes caused by repeated (two courses) injections in the PAN nephropathy rats.
for podcoyte nuclear division nor an increase in the number of podoyctes per glomerular cross section. When podocytes are injured, they become detached from the glomerular basement membrane (GBM). Detachment of podocytes from the GBM at such sites, allows the epithelial cells of Bowman's capsule access to the GBM. This lesion is defined as early glomerular adhesion [7] . Such an early adhesion is generally not associated with sclerotic lesions in the corresponding tuft area. These lesions develop later. Proliferation of epithelial cells of Bowman's capsule is observed at the site of adhesion and is involved in their formation [4, 5, [8] [9] [10] [11] [12] . Therefore, it may be important that the factor should be mitogen for epithelial cells of Bowman's capsule in the early adhesive glomerular lesions. However, there have been few studies on the growth factors affecting proliferation of podocytes and epithelial cells of Bowman's capsule. It has been reported that fibroblast growth factor 2 (FGF2) has a proliferative effect on cultured glomerular epithelial cells [13] . Recent studies have shown that treatment of rats with FGF2 induces conspicuous structural changes in podoeytes such as cell hypertrophy and widespread vacuolar formation. Segmental glomerulosclerosis with adhesive lesions was detected in these rats [14, 151 . We previously reported that the expression of FGF2 and FGF receptors was detected in damaged podocytes and epithelial cells of Bowman's capsule of rats with puromycin aminonucleoside (PAN) nephropathy [16] . Floege et al [17] suggest that released FGF2 from sublethal mesangial cell injury may be an important step in the initiation of mesangial proliferative glomerulonephritis. Therefore, we investigated the role of FGF2 in glomerular epithelial cell injury. In the present study, two series of experiments were done with PAN nephropathy rats given FGF2 and FGF2 neutralizing antibodies. The first series of experiments was intended to clarify the effect of FGF2 and FGF2 neutralizing antibodies on rats with PAN nephropathy after the induction of glomerular epithelial cell damage. The second series of experiments was designed to study the effect of FGF2 neutralizing antibody on more severely damaged glomerular epithelial cells of rats by repeated injection with PAN.
Methods

Animals
Male Wistar strain rats (Clea Japan Co., Osaka, Japan) weighing 110 g were used. The animals were housed in metabolic cages (N 5, Anti-FGF2 group) or the equal volume of physiological saline (N = 5, Control group) was injected for four days into the tail vein, and the animals were sacrificed on the 30th day after the start of PAN administration (Fig. 1) . Previous studies reported • -t. • .: •'.r:-0 that clone 3H3 has an immuno-neutralizing activity for FGF2-induced proliferation of human umbilical vein endothelial cells [19] . Also, our study showed inhibition of FGF2-induced proliferation of cultured mesangial cell (data not shown).
Series 2 experiments
More frequent sclerotic lesions with adhesion were produced by intraperitoneal injection of 1.5 mg/l00 g body wt of PAN into rats Time, days After washing in phosphate-buffer saline, bound antibodies were detected using the ABC kit (Vector Co., Barlingame, USA). The bound antibodies were detected using 3,3-diaminobenzidine tetrahydrochioride (DAB) in Tris-buffer saline containing 0.02% hydrogen peroxide for 5 to 10 minutes. The number of PCNA (+) and ED1 (+) cells along with 50 glomeruli were observed.
Glomerular desmin expression was evaluated semiquantitatively in four grades: Grade 0 (0 to 5%), Grade 1 (5 to 25%), Grade 2 (25 to 75%), Grade 4 (> 75%), depending on the appearance of positive staining. Control study. Normal Wistar strain rats were divided into four groups, which received either 10 g of recombinant FGF2 (N =2; Intergen Co., NY, USA), 40 g of FGF2-neutralizing antibody (N = 2; clone 3H3), the equal volume of mouse IgG (N = 2), or the equal volume of physiological saline (N = 2), respectively, once a day for a period of four days. Every day 24-hour urinary protein excretion was checked. Twenty-five days after the first day of injection, these rats were sacrificed. The four groups had no significant difference in the 24-hr urinary protein excretion and PCNA (+) glomerular cells. Adhesive glomeruli and desmin stained glomeruli were not detected (Fig. 2 ).
Statistical analysis
All values were expressed as the mean so. Comparisons between groups were made using the Student's t-test or Welch's t-test.
for five consecutive days [18] , on the first and 25th days, respectively. After the last PAN injection, 40 j.g of FGF2-neutralizing antibody (clone 3H3; N = 5, MoAb group) or an equal volume of mouse IgG (N = 5, Group IgG) was injected for five days into the tail vein, and the animals were sacrificed on the 40th day after the start of PAN administration (Fig. 1) .
Level of urinary protein Daily urinary protein levels were determined by the KingsburyClark's method.
Renal morphology and immunohistochemistiy. Rats were perfused with 4% paraformaldehyde (PFA) via the left ventricle, and both kidneys were fixed. After dehydration, the kidneys were embedded in paraffin and thin sections were prepared. After deparaffinization, periodic acid-Schiff (PAS) or periodic acid methenamine silver (PAM) staining was performed on these sections, and the number of adhesive glomeruli per 100 glomeruli was counted. Even if there was more than one adhesive lesion in a glomerulus, they were counted as a single adhesive glomerulus. The following antibodies were used for immunoperoxidase staining of 4% PFA fixed paraffin sections: PC1O (a cell proliferation marker; Dako Co., Denmark), which is a monoclonal antibody to the proliferating cell nuclear antigen (PCNA), EDI (Serotec, Oxford, UK), a monoclonal antibody to monocyte/macrophage, which checked presence of these cells in glomeruli, and D33 (Dako), a monoclonal antibody to desmin that is detected in podocyte injury [20] . The sections were treated with 0.3% hydrogen peroxidase in methanol for 30 minutes at room temperature to inactivate endogenous peroxidase. Then they were immersed in non-immunohorse serum for 30 minutes, washed in 0.02 M phosphate-buffer saline (pH 7.2), and were made to react with primary monoclonal antibodies for two hours at room tempera-
Results
Series 1 experiments
Level of urinary protein. Our previous study showed that the 24-hr urinary protein excretion of normal adult rats was less than 10 mg. Onset of massive proteinuria was noted ten days after the intraperitoneal injection of PAN. This proteinuria gradually increased. Especially significant differences in the increase of urinary protein were observed on the 16th day, being more in group F than in the other two groups. When compared, the level of urinary protein in group M was found to be less than that of group C on the 21st day (Fig. 3) .
Renal morphology and immunohistochemistty. The morphological changes of podocytes (such as cytoplasmic vacuolar formation and accumulation of PAS positive materials) were detected more frequently in the FGF2 group. Other morphological changes in the glomeruli consisted of hypertrophy and proliferation of epithelial cells of Bowman's capsule. Also, a mitotic figure of the epithelial cells of Bowman's capsule was easily detected at the site of glomerular adhesive lesions (Fig. 4) . The number of adhesive glomeruli was higher in the FGF2 group and lower in the Anti-FGF2 group compared to the Control group (Fig. 5) .
Adhesive lesions appeared to be randomly distributed in the three groups. The PCNA (+) glomerular cells were mainly podocytes, and the number of epithelial cells of Bowman's capsule in the FGF2 group was higher than in the other two groups (Fig. 6A ).
There was no difference in the number of EDI (+) cells in glonieruli in among the three groups. They were found exclusively in the mesangial areas and capillary lumens (Fig. 6B) . These epithelial cells of Bowman's capsule were detected not only in adhesive lesions, but also in other places of the Bowman's capsule. The desmin score of glomeruli was lower in the Anti-FGF2 group than in the other two groups; however, no significant difference was noted between the Control and FGF2 groups (Table 1) .
Series 2 experiments
Level of urinaty protein. An increase in urinary protein excretion was observed in both groups, hut on the 40th day, the level of proteinuria in the MoAb group decreased abruptly (Fig. 7) .
Renal morphology and iinrnunohistochemisiiy. In the same way as in series 1, the MoAb group had fewer adhesive glomeruli than the IgG group (Figs. 8 and 9 ). The frequency of PCNA (+) glomerular cells and epithelial cells of Bowman's capsule was also higher in the MoAb group than in the lgG group. However, there was no difference in the number of EDI (+) cells. Also, the desmin score of glomeruli was lower in the MoAb group than in the IgG group (Fig. bA, B and Table 2 ).
Discussion
This study showed that intravenous injection of FGF2 markedly increased the glomerular podocyte injury and proliferation of epithelial cells of Bowman's capsule in PAN nephropathy. The previous study reported that FGF2 rapidly cleared up from serum after intravenous injections and was deposited to a greater extent in solid organs than in blood vessel walls. Deposition was greatest in Ihe kidney followed by the liver, and spleen and was substantially smaller in the heart and lung [21] . The present data as well as recent in vivo and in vitro findings suggested that FGF2 might be one of the factors involved. FGF is a member of a family of polypcptidc growth factors (of which nine have been identified to date), which in turn are capable of being hound to any of the components of the tyrosine kinase receptors (4 [25, 26] . FGF2 expression was observed in podocytes and epithelial cells of Bowman's capsule of PAN nephropathy rats [16] . FGF2 emits no signal before secretion, so the mechanism of its release is unclear. In cell injury, FGF2 is released from its cytosolic storage sites through plasma membrane disruption [27] . Extracellularly, it is bound to hcparan sulfate proteoglycans where it may be released by heparin and heparitinases [28] . Disruption of the cytoplasm of damaged podocytes was observed under an electron microscope (data not shown), suggesting that FGF2 may have a paracrine influence on the proliferation of epithelial cells of Bowman's capsule. Since FGF2 mRNA is present in the epithelial cells of Bowman's capsule, an autocrine influence cannot be denied.
Although no proliferative action of FGF2 is observed in normal glomeruli, such an effect on damaged mesangial cells has already been reported [29] . The number of PCNA (+) glomerular cells, epithelial cells of Bowman's capsule, EDI (+) cells and desmin score per 50 glomeruli.
Data arc means SD. a p < 0.05; P < 0.01 been identified to date) [22] . One of these growth factors, FGF2, has received particular attention as a potential mediator of glomerular injury. The role of FGF2 in in vivo models of wound healing, angiogenesis, and cardiovascular development has been demonstrated. A number of glomerular cell types, such as mesangial cells [23] , endothelial cells [24] and visceral epithelial cells [13] , can be stimulated to proliferate in response to exposure to FGF2. This implies that each of these cell types bears specific FOF receptors. In our previous studies, FGF2 protein was found in the normal rat glomeruli, but its mRNA was not detected. In the present study, many PCNA (+) podocytes and epithelial cells of Bowman's capsule were observed when FGF2 was injected following PAN, and the PCNA (+) cells decreased when an FGF2-neutralizing antibody was injected. No monoeyte/maerophage was found in adhesive lesions either. This result was considered to be related to FGFR mRNA expression by podoeytes and epithelial cells of Bowman's capsule, suggesting an in situ hybridization [17] . However, further detailed studies are necessary for more clear and detailed understanding of the role of FGFRI-4. PCNA (+) podoeytes showed morphological abnormalities, such as vacuolization and accumulation of PAS-positive materials in the cytoplasm. Since the desmin score, (a marker for damaged podocytes), was reduced by administration of the FGF2-neutralizing antibody, there is a possibility that FGF2 may play a role in podocytc damage. Some evidence suggests that nuclear division in podocytcs was not followed by complete cell division.
Kriz et al recently did not observe an increase in the absolute number of podocytes despite nuclear division in podocytcs after long-term, high-dose administration of FGF2 to rats [15] . The FGF2-induced podoeyte changes had severe structural abnormalities, which probably showed the important role of podocytes in maintaining the glomerular permcsclectivity [30] . This indicated that FGF2 injection also increased the occurrence of protcinuria. Also, it has been suggested that FGF2 might become relevant in those podoeytes that have more sensitivity to FGF2 due to an up-regulation of FGF2 receptors. FGF2 did not induce proliferation of glomerular cells in normal rats. Furthermore, Floege et al [31, HIV-associated nephropathy has been linked to FGF2 [33] . indicate that FGF2 released from injured podocytes may act HW-nephropathy consists of rapidly progressing focal glomeru-synergistically with other damaging mechanisms. loscierosis characterized by severe podocyte lesions [34] . These Moreover, in vitro data from a previous study showed that 
